中西医结合治疗非小细胞肺癌的研究概况  

The Research Summary of Treating Nonsmall-Cell Lung Cancer with Traditional Chinese and Western Medicine

作　　者：白浩然 李和根[2] 

机构地区：[1]上海中医药大学附属龙华临床医学院,上海 [2]上海中医药大学附属龙华医院肿瘤科,上海

出　　处：《中医学》2017年第1期24-28,共5页Traditional Chinese Medicine

基　　金：上海市进一步加快中医药事业发展三年行动计划(ZY3-CCCX-3023);上海申康医院发展中心临床科技创新项目任务(SHDC12016114);国家中医药管理局国家中医临床研究基地业务建设科研专项(JDZX2012125)。

摘　　要：肺癌是目前常见的恶性肿瘤之一,而且是当前威胁人们健康及生活质量,甚至生命的主要杀手,其发病率和死亡率在全球恶性肿瘤中占据首位。其中非小细胞肺癌(NSCLC)是肺癌中最为常见的,作为肺癌中的一大类别,在肺癌中占80%左右。手术治疗非小细胞肺癌具有疗效确切的特点,但许多晚期患者,无法接受手术治疗,且对放化疗等耐受性差。中医药治疗作为肿瘤治疗的一种方法,在长期的治疗实践中积累了丰富的经验,并与现代医学结合,得到了肿瘤学术界的认可。现将中西医结合治疗非小细胞肺癌的研究进展作一综述。As one of the most common malignant tumors, lung cancer is not only a health risk but the leading killer of human. Lung cancer is still among the most frequently occurring malignancies and is the leading cause of death in the world. Non-small-cell lung cancer (NSCLC) is the most common lung cancer and accounts for about 80% of all. Surgery remains the choice of treatment if patients are diagnosed at an early stage. However, for many patients in advanced stages who cannot choose surgery and tolerate intensive chemotherapy poorly, traditional Chinese medicine, combined with western medicine, could be an effective treatment with rich experience gained through long-term practice. This article will review the research progress of the treatment of non-small cell lung cancer with traditional Chinese medicine and western medicine.

关 键 词：非小细胞肺癌 中医药 综述 

分 类 号：R73[医药卫生—肿瘤]